These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
832 related articles for article (PubMed ID: 18271619)
21. Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular Ligands. Lindesmith LC; Brewer-Jensen PD; Mallory ML; Yount B; Collins MH; Debbink K; Graham RL; Baric RS J Virol; 2019 Jan; 93(2):. PubMed ID: 30355694 [TBL] [Abstract][Full Text] [Related]
22. Genetic Manipulation of Human Intestinal Enteroids Demonstrates the Necessity of a Functional Fucosyltransferase 2 Gene for Secretor-Dependent Human Norovirus Infection. Haga K; Ettayebi K; Tenge VR; Karandikar UC; Lewis MA; Lin SC; Neill FH; Ayyar BV; Zeng XL; Larson G; Ramani S; Atmar RL; Estes MK mBio; 2020 Mar; 11(2):. PubMed ID: 32184242 [TBL] [Abstract][Full Text] [Related]
23. Population Genomics of GII.4 Noroviruses Reveal Complex Diversification and New Antigenic Sites Involved in the Emergence of Pandemic Strains. Tohma K; Lepore CJ; Gao Y; Ford-Siltz LA; Parra GI mBio; 2019 Sep; 10(5):. PubMed ID: 31551337 [TBL] [Abstract][Full Text] [Related]
26. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens. Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876 [TBL] [Abstract][Full Text] [Related]
27. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability. Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750 [TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid. Mahar JE; Donker NC; Bok K; Talbo GH; Green KY; Kirkwood CD J Virol; 2014 Feb; 88(4):1942-52. PubMed ID: 24284328 [TBL] [Abstract][Full Text] [Related]
29. Characterization of emerging GII.g/GII.12 noroviruses from a gastroenteritis outbreak in the United States in 2010. Takanashi S; Wang Q; Chen N; Shen Q; Jung K; Zhang Z; Yokoyama M; Lindesmith LC; Baric RS; Saif LJ J Clin Microbiol; 2011 Sep; 49(9):3234-44. PubMed ID: 21752978 [TBL] [Abstract][Full Text] [Related]
30. Genotype distribution of norovirus around the emergence of Sydney_2012 and the antigenic drift of contemporary GII.4 epidemic strains. Zhang J; Shen Z; Zhu Z; Zhang W; Chen H; Qian F; Chen H; Wang G; Wang M; Hu Y; Yuan Z J Clin Virol; 2015 Nov; 72():95-101. PubMed ID: 26476326 [TBL] [Abstract][Full Text] [Related]
33. Genomic and biological characterization of a pandemic norovirus variant GII.4 Sydney 2012. Ge L; Chen X; Liu J; Zheng L; Chen C; Luo S; Guo P; Kong J; Song Y; Huo Y Virus Genes; 2020 Apr; 56(2):174-181. PubMed ID: 31912284 [TBL] [Abstract][Full Text] [Related]
34. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China. Huo Y; Zheng L; Chen X; Ge L; Wang Y Microb Pathog; 2017 Apr; 105():131-137. PubMed ID: 28219831 [TBL] [Abstract][Full Text] [Related]
35. Identification of Human Norovirus GII.3 Blockade Antibody Epitopes. Yi Y; Wang S; Wang X; Xiong P; Liu Q; Zhang C; Yin F; Huang Z Viruses; 2021 Oct; 13(10):. PubMed ID: 34696487 [TBL] [Abstract][Full Text] [Related]
36. Pandemic GII.4 Sydney and Epidemic GII.17 Kawasaki308 Noroviruses Display Distinct Specificities for Histo-Blood Group Antigens Leading to Different Transmission Vector Dynamics in Pacific Oysters. Morozov V; Hanisch FG; Wegner KM; Schroten H Front Microbiol; 2018; 9():2826. PubMed ID: 30542329 [TBL] [Abstract][Full Text] [Related]